Apolipoprotein B-gene DNA polymorphisms associated with myocardial infarction

Area of Science:

• Cardiovascular Genetics
• Molecular Biology

Background:

• Apolipoprotein B (apoB) is the primary protein in low-density lipoproteins (LDL).
• Elevated apoB levels are associated with increased risk of coronary heart disease.
• The role of genetic variation in apoB in myocardial infarction (MI) risk is not fully understood.

Purpose of the Study:

• To investigate the association between genetic variations in the apolipoprotein B gene and myocardial infarction.
• To determine if specific apoB gene polymorphisms are risk factors for MI.

Main Methods:

• Studied restriction-fragment-length polymorphisms (RFLPs) in the apolipoprotein B gene.
• Utilized Southern blot analysis with specific DNA probes and endonucleases (XbaI, EcoRI, MspI).
• Analyzed DNA from 84 MI patients and 84 matched controls.

Main Results:

• Identified several apoB gene alleles: X1, X2, X3 (from XbaI digestion) and R1, R2 (from EcoRI digestion).
• Identified insertion-deletion polymorphisms (ID1, ID2) using MspI digestion.
• Alleles X1, R1, and ID1 were found at significantly higher frequencies in MI patients compared to controls (P < 0.01).
• No significant association was found between these alleles and variations in LDL cholesterol or apoB levels.

Conclusions:

• Genetic variations at the apolipoprotein B locus may be associated with myocardial infarction.
• These genetic polymorphisms could represent a novel and independent risk factor for MI.
• The functional significance of these identified apoB gene variations remains uncertain.